01.12.2012 Views

View - ResearchSpace@Auckland - The University of Auckland

View - ResearchSpace@Auckland - The University of Auckland

View - ResearchSpace@Auckland - The University of Auckland

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>The</strong> enzyme <strong>of</strong> this second pathway - guanosine triphosphate cyclohydrolase I - is in turn<br />

affected by certain cytokines and inflammatory products. So while this operates as a control<br />

for the is<strong>of</strong>orms, in fact the limiting effect may be more important for the iNOS enzyme<br />

which is present in higher amounts, particularly in infection and inflammation when much<br />

greater levels <strong>of</strong> these cytokines are around and when the production <strong>of</strong> NO is higher (Stuehr<br />

1999; Werner-Felmayer, Golderer et al.2002). This will be discussed in more depth below in<br />

Section 3.4.3 (ii).<br />

<strong>The</strong> rates <strong>of</strong> formation <strong>of</strong> NO and L-citrulline are non linear for all isoenzyme forms which<br />

demonstrates there is negative feedback inhibition and this is also a mechanism to control<br />

overproduction (Rogers and Ignarro 19921, Assreuy, Cunha et al. 1993; Bastian and Hibbs<br />

r9e4).<br />

In addition, there are some differing control mechanisms operating for each <strong>of</strong> the constitutive<br />

isoenzymes. Firstly, the nNOS form can be regulated by alternative splicing to give multiple<br />

transcripts and molecular diversity. This means that the protein can be spliced in different<br />

places giving different molecular weights which possibly fulfil a differing role. <strong>The</strong>re are two<br />

major transcriptional clusters identified within the human nNOS gene, with one form lacking<br />

approximately 315 base pairs, or 105 amino acids and this smaller version is seen<br />

predominantly in the peripheral nervous system, renal tract and in the male reproductive tract<br />

(Papapetropoulos, Rudic et al. 1999).<br />

Secondly, regarding the eNOS form, it was noted that some physiological situations led to<br />

increased eNOS expression such as shear stress and exercise training (Nishida, Harrison et al.<br />

1992; Sessa, Ftitchard et al. 1994; Uematsu, Ohara et al. 1995), and situations <strong>of</strong> local<br />

hypoxia (Marsden, Schappert et al. 1992). While both iNOS and nNOS exist in soluble forms,<br />

eNOS exists in a particulate form (Nathan 1992). <strong>The</strong> importance <strong>of</strong> this is that the proper<br />

localisation <strong>of</strong> eNOS is a pre-requisite to enable it to interact with specific proteins that will<br />

allow full activity. Post translation, cNOS undergoes a process <strong>of</strong> acylation (Shaul, Smart et<br />

al. 1996) which appears necessary to anchor the enzyme to the membrane in the Golgi<br />

apparatus, and in the plasmalemmal vesicles (the caveolae). <strong>The</strong>re are some regulatory<br />

proteins that play a role in promoting this within the cells (C-protein coupled receptors,<br />

caveolin or Hsp90), that contribute to the correct localisation and that can also be individually<br />

influenced therefore contributing to more or less NO being produced. For example, Hsp90<br />

increases with increased histamine or fluid shear stress (Garcia-Cardena, Fan et al. 1998).<br />

Changes in phosphorylation <strong>of</strong> eNOS have been observed with shear stress (Corson, James et<br />

84

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!